Topic: Talcum Powder

Johnson & Johnson reached a $700 million settlement over allegations of misleading consumers about the safety of its talcum-based baby powder. Additionally, the company agreed to pay $150 million to Washington State to settle claims related to its role in the opioid crisis. These settlements follow the multi-billion dollar bankruptcy of Purdue Pharma and the Sackler family's legal battles, highlighting ongoing accountability efforts within the pharmaceutical industry.

Johnson & Johnson is undergoing a global overhaul as it faces massive legal liabilities from talcum powder and asbestos lawsuits. Meanwhile, Merck's COVID-19 drug is reportedly linked to viral mutations, potentially putting the company at a disadvantage against competitors like Pfizer. These financial pressures are forcing major shifts in the pharmaceutical industry.